Constellation Pharmaceuticals Update on MANIFEST Clinical Trial of CPI-0610 in Myelofibrosis

constellation pharmaceuticals MANIFEST clinical trial of CPI-0610 in myelofibrosis

CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) – Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today provided an update on progress in the MANIFEST Phase 2 clinical trial of CPI-0610 in myelofibrosis (MF). The Company also reviewed its 2018 accomplishments and announced its data […]

04: First Hematologist Appointment for Polycythemia Vera Patient

polycythemia vera PV patient getting phlebotomy treatment

MPN Chronicles Podcast – 04, PV Reporter, Always Ask Your Doctor for your CBC or your test results and keep a binder to Monitor your Progress by David Wallace After 2 visits to the ER, I finally had my first hematologist meeting.  She reviewed the tests that were done in the ER and ran a […]

PV Reporter partners with PAN Foundation on MPN Patient Assistance Programs

MPN patient assistance programs PAN Foundation

Patient Assistance Programs, Medications for MPN Patients by David Wallace PV Reporter is very proud to announce a new partnership with the PAN Foundation.  Myeloproliferative Neoplasm (MPN) patients may be eligible for $8,500 per year (or more if a 2nd grant is needed/approved) in assistance assuming you meet the eligibility criteria which are very reasonable. […]

Breaking news on Celgene’s Fedratinib for Myelofibrosis patients!

Breaking news on Fedratinib by Celgene, expanded use program for myelofibrosis patients

by David Wallace Fedratinib by Celgene, offered on Expanded Access Program (EAP) for Myelofibrosis Patients This is hot off the press!  So hot, that no one has covered it until now – brought to you by PV Reporter.  I knew after combing through the ASH (American Society of Hematology) abstracts that something was missing.  That […]

Safety and efficacy of combo therapy of interferon-a2 and ruxolitinib in polycythemia vera and myelofibrosis

combo therapy for MPNs pegasys and ruxolitinib

by Stine Ulrik Mikkelsen, Lasse Kjær, Mads Emil Bjørn, Trine Alma Knudsen, Anders Lindholm Sørensen, Christen Bertel Lykkegaard Andersen, Ole Weis Bjerrum, Nana Brochmann, Daniel El Fassi, Torben A. Kruse, Thomas Stauffer Larsen, Hans Torben Mourits‐Andersen, Claus Henrik Nielsen, Niels Pallisgaard, Mads Thomassen, Vibe Skov, Hans Carl Hasselbalch Abstract Interferon‐α2 reduces elevated blood cell counts […]

03: Learn Benefits of Becoming your own MPN Patient Advocate

MPN Patient advocate

MPN Chronicles Podcast – 03, PV Reporter, Day 3, 2nd Trip to ER in 3 Days by David Wallace Chest pain continued to worsen after 1st trip to the ER, 2 days earlier.  This was an immediate cause for immediate concern and a return trip to the ER on day 3 with Polycythemia Vera (PV).  […]

Spotlight on MPN Life

Publisher’s Note: PV Reporter will spotlight organizations and groups from time to time that have a unique message to share and help MPN patients as well.  I have known Jeremy since I first got involved in the Facebook Support Groups 9 years ago.  He had a positive influence on me personally and I have seen […]

Cancer Survivor helping others – Newspaper article on David Wallace

PV Reporter, David Wallace, MPN Awareness, patient advocate

PV Reporter gets Local News Coverage for his work on Patient Advocacy and MPN Awareness by Lacey Hampton David Wallace’s experience after being diagnosed with a type of blood cancer led him to want to raise awareness and help others. He created PV Reporter, a website that provides easy access to information on Myeloproliferative Neoplasms […]

Repurposed Drug Interferon for the Treatment of Polycythemia Vera

interferon for MPN treatment

Drug Gives Woman with PV – Blood Cancer the Gift of Life This patient story was featured on ABC 7, Chicago News.  It is encouraging to see MPN patients share their story on the local TV news media.  The MPN Research Foundation also covered Karrie’s story in their latest newsletter.  I wish more patients would […]

Structure of Protein Pair Provides Blueprint for Future Drugs

New MPN research for medications

Publishers Note: Researcher Associate Professor Jeff Babon advises: This is very early stage research.  It gives us the blueprint to begin to develop a medicine that targets the molecule, JAK2, that is responsible for PV and other MPNs in a novel way, the same way that is used by own our natural JAK2-inhibitory protein (called SOCS1). […]

error: Content is protected !
Malcare WordPress Security